With international growth comes opportunity, new legal issues, and increased business risks. Companies considering expansion into China must be prepared to protect their unique technologies and services.
Topics for this seminar included a discussion of Chinese intellectual property law and practical steps foreign businesses can take to minimize the risks of doing business in China. The panel addressed:
- Investing in China: Choice of investment and business vehicles
- Chinese patent, trademark, copyright and trade secret law
- Protecting IP assets before and after entering the Chinese marketplace
- Establishing best practices for developing and licensing your IP assets in China
- Tips and strategies for success
This was an interactive panel session led by Thomas I. Elkind of Foley’s Litigation Department, Xueqing Linda Ji of Foley’s Business Law Department and Bethew B. Jennings III of Halliburton.
“Safeguarding Your Intellectual Property While Doing Business in China” is part of Foley’s 2007 Boston Executive Briefings Series.
People
Related Insights
19 February 2025
Manufacturing Industry Advisor
What Every Multinational Company Should Know About … The New Steel and Aluminum Tariffs
On February 10, 2025, President Trump signed proclamations titled Adjusting Imports of Steel Into the United States and Adjusting Imports of Aluminum into the United States. The proclamations cover both steel and aluminum tariffs, which will be raised to a flat 25%.
18 February 2025
Labor & Employment Law Perspectives
Noncompete Bans – Next Up: Ohio
This month, Ohio joined the list of states with pending legislation to ban noncompetes. With the FTC noncompete ban blocked on a nationwide basis last year, Ohio lawmakers introduced a bill on February 5, 2025, that would ban noncompete contracts as a condition of employment in the state.
18 February 2025
DEA Delays Final Buprenorphine Rule
The Department of Health and Human Services and the Drug Enforcement Administration have delayed the effective date of the final rule regarding telemedicine prescribing of buprenorphine to March 21, 2025, and have requested public comments on the rule.